Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Multiple oncogenic viruses are present in human breast tissues before development of virus associated breast cancer.

Lawson JS, Glenn WK.

Infect Agent Cancer. 2017 Oct 16;12:55. doi: 10.1186/s13027-017-0165-2. eCollection 2017.

2.

Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms.

Lau HY, Tang J, Casey PJ, Wang M.

Oncogene. 2017 Jul 6;36(27):3934-3942. doi: 10.1038/onc.2016.508. Epub 2017 Feb 13.

3.

Dissecting the Biology of Menstrual Cycle-Associated Breast Cancer Risk.

Atashgaran V, Wrin J, Barry SC, Dasari P, Ingman WV.

Front Oncol. 2016 Dec 26;6:267. doi: 10.3389/fonc.2016.00267. eCollection 2016. Review.

4.

Conisation as a marker of persistent human papilloma virus infection and risk of breast cancer.

Søgaard M, Farkas DK, Ording AG, Sørensen HT, P Cronin-Fenton D.

Br J Cancer. 2016 Aug 23;115(5):588-91. doi: 10.1038/bjc.2016.150. Epub 2016 Jun 2.

5.

A/T gap tolerance in the core sequence and flanking sequence requirements of non-canonical p53 response elements.

Cai BH, Chao CF, Lin HC, Huang HY, Kannagi R, Chen JY.

J Biochem. 2016 Jun;159(6):563-72. doi: 10.1093/jb/mvw005. Epub 2016 Jan 27.

6.

Human Papilloma Viruses and Breast Cancer.

Lawson JS, Glenn WK, Salyakina D, Delprado W, Clay R, Antonsson A, Heng B, Miyauchi S, Tran DD, Ngan CC, Lutze-Mann L, Whitaker NJ.

Front Oncol. 2015 Dec 16;5:277. doi: 10.3389/fonc.2015.00277. eCollection 2015.

7.

Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling.

Archibald A, Al-Masri M, Liew-Spilger A, McCaffrey L.

Mol Biol Cell. 2015 Oct 15;26(20):3578-95. doi: 10.1091/mbc.E15-05-0265. Epub 2015 Aug 12.

8.

Disruptive chemicals, senescence and immortality.

Carnero A, Blanco-Aparicio C, Kondoh H, Lleonart ME, Martinez-Leal JF, Mondello C, Scovassi AI, Bisson WH, Amedei A, Roy R, Woodrick J, Colacci A, Vaccari M, Raju J, Al-Mulla F, Al-Temaimi R, Salem HK, Memeo L, Forte S, Singh N, Hamid RA, Ryan EP, Brown DG, Wise JP Sr, Wise SS, Yasaei H.

Carcinogenesis. 2015 Jun;36 Suppl 1:S19-37. doi: 10.1093/carcin/bgv029. Review.

9.

The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.

Zhang L, Wu J, Ling MT, Zhao L, Zhao KN.

Mol Cancer. 2015 Apr 17;14:87. doi: 10.1186/s12943-015-0361-x. Review.

10.

Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction bias.

Hines WC, Yaswen P, Bissell MJ.

Nat Commun. 2015 Apr 21;6:6927. doi: 10.1038/ncomms7927.

11.

The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.

Choe M, Brusgard JL, Chumsri S, Bhandary L, Zhao XF, Lu S, Goloubeva OG, Polster BM, Fiskum GM, Girnun GD, Kim MS, Passaniti A.

J Cell Biochem. 2015 Oct;116(10):2210-26. doi: 10.1002/jcb.25171.

12.

The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells.

Bele A, Mirza S, Zhang Y, Ahmad Mir R, Lin S, Kim JH, Gurumurthy CB, West W, Qiu F, Band H, Band V.

Cell Cycle. 2015;14(7):990-1000. doi: 10.1080/15384101.2015.1006982.

13.

Spontaneous immortalization of mouse liver sinusoidal endothelial cells.

Zhao X, Zhao Q, Luo Z, Yu Y, Xiao N, Sun X, Cheng L.

Int J Mol Med. 2015 Mar;35(3):617-24. doi: 10.3892/ijmm.2015.2067. Epub 2015 Jan 13.

14.

Collagen VI and hyaluronan: the common role in breast cancer.

Karousou E, D'Angelo ML, Kouvidi K, Vigetti D, Viola M, Nikitovic D, De Luca G, Passi A.

Biomed Res Int. 2014;2014:606458. doi: 10.1155/2014/606458. Epub 2014 Jul 14. Review.

15.

Phenotypic plasticity in normal breast derived epithelial cells.

Sauder CA, Koziel JE, Choi M, Fox MJ, Grimes BR, Badve S, Blosser RJ, Radovich M, Lam CC, Vaughan MB, Herbert BS, Clare SE.

BMC Cell Biol. 2014 Jun 10;15:20. doi: 10.1186/1471-2121-15-20.

16.

Genetically engineered mice as experimental tools to dissect the critical events in breast cancer.

Menezes ME, Das SK, Emdad L, Windle JJ, Wang XY, Sarkar D, Fisher PB.

Adv Cancer Res. 2014;121:331-82. doi: 10.1016/B978-0-12-800249-0.00008-1. Review.

17.

OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.

Ng WL, Chen G, Wang M, Wang H, Story M, Shay JW, Zhang X, Wang J, Amin AR, Hu B, Cucinotta FA, Wang Y.

Cell Death Dis. 2014 Jan 23;5:e1024. doi: 10.1038/cddis.2013.563.

18.

Viruses and breast cancer.

Lawson JS, Heng B.

Cancers (Basel). 2010 Apr 30;2(2):752-72. doi: 10.3390/cancers2020752.

19.

Role of viruses in the development of breast cancer.

Alibek K, Kakpenova A, Mussabekova A, Sypabekova M, Karatayeva N.

Infect Agent Cancer. 2013 Sep 2;8:32. doi: 10.1186/1750-9378-8-32. eCollection 2013. Review.

20.

The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis.

Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, Cotari J, Alpaugh ML, de Stanchina E, Manova K, Li M, Bonafe M, Ceccarelli C, Taffurelli M, Santini D, Altan-Bonnet G, Kaplan R, Norton L, Nishimoto N, Huszar D, Lyden D, Bromberg J.

Neoplasia. 2013 Jul;15(7):848-62.

Supplemental Content

Support Center